(Q46641267)

English

Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis

scientific article published on 27 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

multiple sclerosis

0 references

7

object named as

Michael Strupp

1 reference

Europe PubMed Central

23 December 2017

author name string

Vera Carina Zingler

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Michael Nabauer

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Klaus Jahn

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Ariane Gross

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Reinhard Hohlfeld

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Thomas Brandt

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

publication date

27 July 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

European Neurology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

54

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

28-33

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

Cognitive change following MPTP exposure.

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1159%2F000087242

21 January 2018

Identifiers

10.1159/000087242

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16088176

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46641267&oldid=2123679154"